News Preview
Mineralys Therapeutics, Inc. (MLYS) Presents at American Heart Association Hypertension Scientific Sessions 2026 - Slideshow
Mineralys Therapeutics, Inc. (MLYS) presented at the American Heart Association Hypertension Scientific Sessions 2026.
The company discussed its pipeline of hypertension treatments, including a novel approach to treating resistant hypertension.
MLYS' stock price rose in response to the presentation.
Want to stay up to date with the world events at sea or at home?
Explore Navvyx News - the best News app for seafarers.